<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study investigated the association of hepatocyte nuclear factor 4 (HNF4) alpha single nucleotide polymorphisms (SNPs) with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with or without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in Malaysia </plain></SENT>
<SENT sid="1" pm="."><plain>Nine HNF4 alpha SNPs were genotyped in 390 type 2 diabetic subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, 135 type 2 diabetic subjects without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and 160 control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>The SNPs rs4810424, rs1884613, and rs2144908 were associated with protection against type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (recessive P = 0.018, OR 0.32; P = 0.004, OR 0.25; P = 0.005, OR 0.24, respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>The 6-SNP haplotype2 CCCGTC containing the risk genotype of these SNPs was associated with higher risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with or without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (P = 0.002, OR 2.2; P = 0.004, OR 3.1) </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggest that HNF4 alpha SNPs and haplotypes contributed to increased type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> risk in the Malaysian population </plain></SENT>
</text></document>